Anticonvulsant potential of the phytocannabinoid, cannabidivarin, on epilepsy disease progression
Epilepsy affects about 0.8% of individuals [1]. Many treatments are available but more effective and better-tolerated antiepileptic drugs (AEDs) with new mechanisms of actions (MOAs) are needed [2, 3]. Cannabis has been historically used to treat epilepsy [4]. In our laboratory, we have demonstrated...
Main Author: | Amada, Naoki |
---|---|
Published: |
University of Reading
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.657606 |
Similar Items
-
The effect of the phytocannabinoid cannabidivarin (CBDV) on synaptic transmission in a model of epilepsy
by: Hill, Charlotte Louise
Published: (2016) -
Epilepsy
by: McCallum, A. J.
Published: (1908) -
Genetic studies of the common epilepsies : genome-wide association studies in the partial epilepsies
by: Catarino, C. B.
Published: (2014) -
Pathophysiology of seizure onset in human focal epilepsy and its relevance to epilepsy surgery
by: Jimenez Jimenez, Diego Mauricio
Published: (2016) -
Quantitative imaging in epilepsy (PET)
by: McGinnity, Colm Joseph
Published: (2013)